Gadolinium Lawyers - Taking Part in MultiDistrict Litigation
Peter Brodhead has handled numerous actions on behalf of clients harmed by defective medical devices, implants, and pharmaceuticals. Many of his cases have been national in scope. A certified civil trial advocate by the National Board of Trial Advocacy and a Fellow of the International Society of Barristers, he is named on Inside Business magazines' recent list of northeast Ohio's leading lawyers. Brodhead joins William Hawal as liaison counsel for plaintiffs in the gadolinium MRI Contrast Agent MultiDistrict Litigation.
William Hawal was selected by his peers... and voted among The Best Lawyers in America® in the Medical Malpractice Law practice area for 2009. This listing has been called the most respected peer-review publication in the legal profession. For more than 25 years, it has assisted lawyers and clients looking for legal counsel in unfamiliar specialties and in foreign jurisdictions. Mr. Hawal has also been recognized among the top 5% of attorneys in Ohio by the Super Lawyers® magazine. Specializing in Personal Injury and Medical Malpractice practice areas.
NSF / Gadolinium MRI Lawsuits
If you have been diagnosed with nephrogenic systemic fibrosis, you may be eligible to collect money damages. The gadolinium attorneys at Spangenberg, Shibley & Liber have been leaders in the court litigation against the pharmaceutical companies whose MRI contrast agents have been linked to NSF. Spangenberg, Shibley & Liber partners Peter J. Brodhead and William Hawal have been appointed to serve as Plaintiffs’ Liaison Counsel for all of the Federal Court litigation, which is centered here in Cleveland, Ohio. Mr. Brodhead and Mr. Hawal also are actively participating in the taking of evidence in these cases.
What is NSF?
Contrast-enhanced MRIs are a relatively common medical procedure, but several of the contrast agents used with MRIs have been linked to a severe condition called nephrogenic systemic fibrosis (NSF). Gadolinium is a highly toxic heavy metal that is contained in MRI contrast agents. The toxicity of gadolinium in these contrast agents is designed to be neutralized by binding it to a chemical called a chelator. However, if the chelator does not securely hold the gadolinium throughout the time it is in the body, the toxic gadolinium is released and causes NSF. Because renal failure patients take longer to excrete the drug, it is this population of patients who are most commonly affected with NSF.
Gadolinium MRI side effects - Do you or a family member have them?
If you have had a gadolinium MRI and have been diagnosed with nephrogenic systemic fibrosis, you may be eligible for compensation. Information on how you can contact a gadolinium lawyer or file a gadolinium lawsuit is available at the end of this article.
Find out if you have a case Call 877-696-3303 for free consultation contact a gadolinium lawyer.
Have You Had Problems?
For a free confidential consultation about litigation involving nephrogenic systemic fibrosis (NSF). Contact the experienced gadolinium attorneys at the Spangenberg Law Firm today...
Call 877-696-3303
What MRI contrast agents are associated with NSF?
There are five FDA approved gadolinium contrast agents; however, only three of these contrast agents have been credibly implicated in cases of nephrogenic systemic fibrosis. These three gadolinium MRI contrast agents are Omniscan (GE Healthcare), Optimark (Covidien/Mallinckrodt), and Magnevist (Bayer Healthcare). All three of these contrast agents share a common linear design for their chelator that is intended to bind the gadolinium. Other contrast agents use a safer chelator design that builds a “cage” around the gadolinium. These “macrocyclic” contrast agents have not been linked to cases of NSF. In fact, the only proven cause of NSF is exposure to one of these three contrast agents with the linear design.
Five gadolinium-based contrast agents are approved by the FDA for use during an MRI. The trade names for these products are:
- Omniscan
- OptiMARK
- Magnevist
- ProHance
- MultiHance
None of these agents are approved by the FDA for MRA. The dose of gadolinium-based contrast agent given to patients undergoing an MRA is often higher (up to three times) than the approved dose for MRI.
Seeking compensation if you have NSF
If you have been diagnosed with nephrogenic systemic fibrosis, you may be eligible to collect money damages. The gadolinium attorneys at Spangenberg, Shibley & Liber have been leaders in the court litigation against the pharmaceutical companies whose MRI contrast agents have been linked to NSF.
To find out if you have a case Call 877-696-3303 or Contact one of these a gadolinium lawyers.